OpenAI and Anthropic Almost Agreed to Test Each Other’s AI. Then the Deal Quietly Died.
OpenAI and Anthropic Almost Agreed to Test Each Other’s AI. Then the Deal Quietly Died.
Omor Ibne EhsanThu, September 24, 2026 at 3:08 PM UTC
0
ShutterstockQuick Read -
Microsoft's ~27% OpenAI stake and $3.2 billion Anthropic gain put the collapsed cross-testing deal squarely on its balance sheet.
Musk warned liability would be enormous if a lab ships after a rival's documented safety warning, making voluntary cross-testing structurally unstable.
Azure's $100 billion revenue and 30 million Copilot seats position Microsoft to profit most if regulators mandate external AI model validation.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
A safety pact between the two most closely watched frontier labs got as far as the lawyers before it went away. According to reporting summarized on The AI Daily Brief, OpenAI and Anthropic reached the formal contracting stage on an agreement to run mutual safety tests on each other's models, and then, in the words of the coverage, "at some point the deal was abandoned for unknown reasons."
The idea has since picked up prominent endorsements. Elon Musk floated a similar proposal at the All-In Summit, and Mustafa Suleyman, described in the coverage as Microsoft's AI chief, called cross-testing "the smartest safety idea in months."
For a Microsoft (NASDAQ:MSFT) shareholder, the tension is governance and liability. Microsoft holds roughly a 27% stake in OpenAI valued at about $135 billion and booked a $3.2 billion gain on its Anthropic investment in fiscal Q4 2026. When the two labs it is most exposed to cannot agree to check each other's work, the risk migrates onto Microsoft's balance sheet and cloud contracts.
What Cross-Testing Would Actually Require
Giving a rival privileged access to probe your model means handing the company best equipped to exploit it a map of your capabilities, guardrails, and failure modes. That involves competitive disclosure normally protected by trade secret law.
A lab can believe cross-testing is right and still walk away when counsel scores the downside. The commercial cost of revealing where your model breaks is immediate, while the safety benefit is diffuse. That asymmetry is why the arrangement almost certainly cannot stay voluntary.
Learn 7 Ways To Generate Income With A $1,000,000+ Portfolio
If you’ve saved over $1,000,000, this guide is for you. The last thing you want in retirement is to run out of money, you want your money to generate lasting income while you enjoy your life.
Now you can learn the strategies wealthy retirees use to fund their retirement with The Definitive Guide to Retirement Income from Fisher Investments. Download the guide today! (sponsor)
Distillation remains the quiet obstacle, because distillation is the practice of using a stronger model's outputs to train a cheaper model that approximates it. A tester with query access has the raw material to distill.
Liability Is the Argument With a Balance Sheet
Once a documented external warning exists, a company that ships anyway has created a written record of known risk. Musk's framing was blunt: "the liability in that case would be enormous" if a lab shipped after a rival raised a red flag.
That changes the legal calculus for corporate counsel more than any ethics framework does, because the plaintiff's bar reads inboxes, not white papers. It is also why voluntary cross-testing may be structurally unstable. The party that adopts it first inherits the paper trail; the party that stays out avoids it. A rule imposed on everyone removes the asymmetry.
Advertisement
Microsoft might be the listed way to play this.
Microsoft sells into banks, hospitals, and governments that will pay for externally validated models once a regulator requires it. Azure crossed $100 billion in annual revenue, and Microsoft 365 Copilot passed 30 million paid seats, most of it inside those regulated buyers.
A mandatory cross-testing regime would raise the fixed cost of shipping a frontier model. Scale players absorb fixed costs more easily than smaller labs can.
Two dominant labs certifying each other can become a mutual certification arrangement that raises barriers to entry without materially improving safety, and regulators have historically accepted such frameworks.
Bull and Bear Case for MSFT Stock
MSFT Price Target — 24/7 Wall St.
The bull case is that model assurance becomes a paid enterprise requirement, and Microsoft is the vendor best positioned to sell it. Commercial remaining performance obligations of $678 billion, up 84%, describe a book of business that already prices in enterprise trust.
The bear case is that Microsoft carries frontier-lab exposure it does not fully control into a governance environment that is visibly unsettled, at a valuation that has already absorbed significant optimism.
The stock trades at $500.59, up 4.17% year to date and down 0.88% over one year, which suggests the market has largely priced in the AI story. The deciding variable is whether external model validation becomes something enterprise buyers must purchase or stays a press release.
MSFT Analyst Ratings — 24/7 Wall St.
A recent CNBC piece flagged a rare Microsoft bear warming to the shares, which is the kind of sentiment shift that tends to arrive before the fundamental answer does.
Learn 7 Ways To Generate Income With A $1,000,000+ Portfolio
If you’ve saved over $1,000,000, this guide is for you. The last thing you want in retirement is to run out of money, you want your money to generate lasting income while you enjoy your life.
Now you can learn the strategies wealthy retirees use to fund their retirement with The Definitive Guide to Retirement Income from Fisher Investments. Download the guide today! (sponsor)
Contact editorial@247wallst.com for any questions or corrections.
Source: “AOL Money”
